These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 5842513)
1. Progynon, a depot preparation with oestrogenic action, in the treatment of prostatic carcinoma. Birke G; Wadström LB Acta Chir Scand; 1965 Oct; 130(4):388-92. PubMed ID: 5842513 [No Abstract] [Full Text] [Related]
2. Effect of hormones on the growth of virus-transformed hamster prostatic tissue. Fraley EE; Paulson DF Surg Forum; 1968; 19():544-5. PubMed ID: 4304976 [No Abstract] [Full Text] [Related]
3. [Hormone therapy in carcinoma of the prostate]. Marberger H Wien Klin Wochenschr; 1966 Jul; 78(29):512-4 passim. PubMed ID: 5992834 [No Abstract] [Full Text] [Related]
4. [HORMONAL THERAPY OF BREAST AND PROSTATIC CARCINOMA]. MARTZ G Med Klin; 1963 Nov; 58():1964-7. PubMed ID: 14095401 [No Abstract] [Full Text] [Related]
5. [Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)]. Straube W; Braun JS Urologe A; 1974 Jul; 13(4 Pt A):198-201. PubMed ID: 4137442 [No Abstract] [Full Text] [Related]
7. STUDIES IN PROSTATE CANCER BEFORE AND AFTER ORCHIECTOMY. GALLAGHER TF; WHITMORE WF; ZUMOFF B; HELLMAN L Natl Cancer Inst Monogr; 1963 Oct; 12():131-7. PubMed ID: 14072986 [No Abstract] [Full Text] [Related]
8. The adrenal cortex and prostatic cancer. Peeling WB; Griffiths K Proc R Soc Med; 1974 Nov; 67(11):1156-8. PubMed ID: 4438298 [No Abstract] [Full Text] [Related]
9. [Our experience in palliative treatment of certain prostatic cancers by high-dosage estrogens combined with corticotherapy]. Neveu J; Soton G; Roche G; Cisterne JP J Urol Nephrol (Paris); 1977; 83(1-2):143-5. PubMed ID: 875120 [No Abstract] [Full Text] [Related]
11. Status of the treatment of prostatic carcinoma--1964. Prout GR Proc Natl Cancer Conf; 1964; 5():309. PubMed ID: 5889426 [No Abstract] [Full Text] [Related]
12. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer]. Hájek J; Hanselová M; Vrubel F Vnitr Lek; 1981 Sep; 27(9):852-60. PubMed ID: 7293030 [No Abstract] [Full Text] [Related]
13. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer. Kalland T; Haukaas S Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576 [TBL] [Abstract][Full Text] [Related]
14. The questionable use of hormone therapy in advanced carcinoma of the prostate. Murphy GP; Slack NH Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459 [No Abstract] [Full Text] [Related]
15. Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma. Lindstedt E Scand J Urol Nephrol Suppl; 1980; 55():95-7. PubMed ID: 6938044 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients. Lukkarinen O; Hammond GL; Kontturi M; Vihko R Invest Urol; 1980 Jan; 17(4):328-31. PubMed ID: 6444293 [TBL] [Abstract][Full Text] [Related]
17. Treatment of prostatic cancer with TAP-144-SR, a depot preparation of LH-RH agonist (leuprolide). Isurugi K; Niijima T; Akaza H; Aso Y; Koiso K; Fuse M; Okada K; Usami M; Ohashi T; Ueda T; J Chemother; 1989 Jul; 1(4 Suppl):1237-41. PubMed ID: 16312848 [No Abstract] [Full Text] [Related]
18. [Diagnosis and therapy of prostatic carcinoma]. Feustel A Z Urol Nephrol; 1973 Mar; 66(3):221-3. PubMed ID: 4577370 [No Abstract] [Full Text] [Related]
19. [Current value of hormonotherapy in cancer of the prostate]. Cilento A; Baio A Minerva Urol Nefrol; 1984; 36(4):329-35. PubMed ID: 6535279 [No Abstract] [Full Text] [Related]
20. Hormonal therapy: the benefits of postponed initiation. Cockburn AG Urology; 1984 Nov; 24(5 Suppl):24-6. PubMed ID: 6388093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]